Global Adult Vaccine Market Research Report 2020

Global Adult Vaccine Market Research Report 2020

Table of Contents
1 Adult Vaccine Market Overview
1.1 Product Overview and Scope of Adult Vaccine
1.2 Adult Vaccine Segment by Type
1.2.1 Global Adult Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Influenza
1.2.3 Cervical Cancer
1.2.4 Zoster Shingles
1.2.5 Pneumococcal
1.2.6 Meningococcal
1.2.7 MMRV
1.2.8 Hepatitis
1.2.9 DTP
1.2.10 Travel and Miscellaneous
1.3 Adult Vaccine Segment by Application
1.3.1 Adult Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Medical Care Centers
1.3.4 Other
1.4 Global Adult Vaccine Market Size Estimates and Forecasts
1.4.1 Global Adult Vaccine Revenue 2015-2026
1.4.2 Global Adult Vaccine Sales 2015-2026
1.4.3 Adult Vaccine Market Size by Region: 2020 Versus 2026
2 Global Adult Vaccine Market Competition by Manufacturers
2.1 Global Adult Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Adult Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Adult Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Adult Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Adult Vaccine Market Competitive Situation and Trends
2.5.1 Adult Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Adult Vaccine Players (Opinion Leaders)
3 Adult Vaccine Retrospective Market Scenario by Region
3.1 Global Adult Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Adult Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Adult Vaccine Market Facts & Figures by Country
3.3.1 North America Adult Vaccine Sales by Country
3.3.2 North America Adult Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Adult Vaccine Market Facts & Figures by Country
3.4.1 Europe Adult Vaccine Sales by Country
3.4.2 Europe Adult Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Adult Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Adult Vaccine Sales by Region
3.5.2 Asia Pacific Adult Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Adult Vaccine Market Facts & Figures by Country
3.6.1 Latin America Adult Vaccine Sales by Country
3.6.2 Latin America Adult Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Adult Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Adult Vaccine Sales by Country
3.7.2 Middle East and Africa Adult Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Adult Vaccine Historic Market Analysis by Type
4.1 Global Adult Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Adult Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Adult Vaccine Price Market Share by Type (2015-2020)
4.4 Global Adult Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Adult Vaccine Historic Market Analysis by Application
5.1 Global Adult Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Adult Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Adult Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Adult Vaccine Business
6.1 GlaxoSmithKline
6.1.1 Corporation Information
6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.1.3 GlaxoSmithKline Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GlaxoSmithKline Products Offered
6.1.5 GlaxoSmithKline Recent Development
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Adult Vaccine Production Sites and Area Served
6.2.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.2.3 Sanofi Pasteur Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sanofi Pasteur Products Offered
6.2.5 Sanofi Pasteur Recent Development
6.3 Merck
6.3.1 Merck Adult Vaccine Production Sites and Area Served
6.3.2 Merck Description, Business Overview and Total Revenue
6.3.3 Merck Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Merck Products Offered
6.3.5 Merck Recent Development
6.4 Novartis
6.4.1 Novartis Adult Vaccine Production Sites and Area Served
6.4.2 Novartis Description, Business Overview and Total Revenue
6.4.3 Novartis Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.4.5 Novartis Recent Development
6.5 Pfizer
6.5.1 Pfizer Adult Vaccine Production Sites and Area Served
6.5.2 Pfizer Description, Business Overview and Total Revenue
6.5.3 Pfizer Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Pfizer Products Offered
6.5.5 Pfizer Recent Development
6.6 BioCSL (Seqirus)
6.6.1 BioCSL (Seqirus) Adult Vaccine Production Sites and Area Served
6.6.2 BioCSL (Seqirus) Description, Business Overview and Total Revenue
6.6.3 BioCSL (Seqirus) Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 BioCSL (Seqirus) Products Offered
6.6.5 BioCSL (Seqirus) Recent Development
6.7 Protein Sciences
6.6.1 Protein Sciences Adult Vaccine Production Sites and Area Served
6.6.2 Protein Sciences Description, Business Overview and Total Revenue
6.6.3 Protein Sciences Adult Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Protein Sciences Products Offered
6.7.5 Protein Sciences Recent Development
7 Adult Vaccine Manufacturing Cost Analysis
7.1 Adult Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Adult Vaccine
7.4 Adult Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Adult Vaccine Distributors List
8.3 Adult Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Adult Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Adult Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Adult Vaccine by Type (2021-2026)
10.2 Adult Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Adult Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Adult Vaccine by Application (2021-2026)
10.3 Adult Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Adult Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Adult Vaccine by Region (2021-2026)
10.4 North America Adult Vaccine Estimates and Projections (2021-2026)
10.5 Europe Adult Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Adult Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Adult Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Adult Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Adult Vaccine Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Adult Vaccine Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Adult Vaccine Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Adult Vaccine Manufacturers Covered in This Study
Table 5. Global Adult Vaccine Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Adult Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Adult Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Adult Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Adult Vaccine Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Adult Vaccine Sales Sites and Area Served
Table 11. Manufacturers Adult Vaccine Product Types
Table 12. Global Adult Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Adult Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Adult Vaccine Players
Table 16. Global Adult Vaccine Sales (K MT) by Region (2015-2020)
Table 17. Global Adult Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Adult Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Adult Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Adult Vaccine Sales by Country (2015-2020) (K MT)
Table 21. North America Adult Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Adult Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Adult Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Adult Vaccine Sales by Country (2015-2020) (K MT)
Table 25. Europe Adult Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Adult Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Adult Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Adult Vaccine Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Adult Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Adult Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Adult Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Adult Vaccine Sales by Country (2015-2020) (K MT)
Table 33. Latin America Adult Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Adult Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Adult Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Adult Vaccine Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Adult Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Adult Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Adult Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Adult Vaccine Sales (K MT) by Type (2015-2020)
Table 41. Global Adult Vaccine Sales Share by Type (2015-2020)
Table 42. Global Adult Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Adult Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Adult Vaccine Price (USD/MT) by Type (2015-2020)
Table 45. Global Adult Vaccine Sales (K MT) by Application (2015-2020)
Table 46. Global Adult Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Adult Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. GlaxoSmithKline Adult Vaccine Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. GlaxoSmithKline Main Product
Table 52. GlaxoSmithKline Recent Development
Table 53. Sanofi Pasteur Adult Vaccine Corporation Information
Table 54. Sanofi Pasteur Corporation Information
Table 55. Sanofi Pasteur Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Sanofi Pasteur Main Product
Table 57. Sanofi Pasteur Recent Development
Table 58. Merck Adult Vaccine Corporation Information
Table 59. Merck Corporation Information
Table 60. Merck Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Merck Main Product
Table 62. Merck Recent Development
Table 63. Novartis Adult Vaccine Corporation Information
Table 64. Novartis Corporation Information
Table 65. Novartis Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Novartis Main Product
Table 67. Novartis Recent Development
Table 68. Pfizer Adult Vaccine Corporation Information
Table 69. Pfizer Corporation Information
Table 70. Pfizer Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Pfizer Main Product
Table 72. Pfizer Recent Development
Table 73. BioCSL (Seqirus) Adult Vaccine Corporation Information
Table 74. BioCSL (Seqirus) Corporation Information
Table 75. BioCSL (Seqirus) Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. BioCSL (Seqirus) Main Product
Table 77. BioCSL (Seqirus) Recent Development
Table 78. Protein Sciences Adult Vaccine Corporation Information
Table 79. Protein Sciences Corporation Information
Table 80. Protein Sciences Adult Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Protein Sciences Main Product
Table 82. Protein Sciences Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Adult Vaccine Distributors List
Table 86. Adult Vaccine Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Global Adult Vaccine Sales (K MT) Forecast by Type (2021-2026)
Table 91. Global Adult Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 92. Global Adult Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 93. Global Adult Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 94. Global Adult Vaccine Sales (K MT) Forecast by Application (2021-2026)
Table 95. Global Adult Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 96. Global Adult Vaccine Sales (K MT) Forecast by Region (2021-2026)
Table 97. Global Adult Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 98. Global Adult Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Global Adult Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Adult Vaccine
Figure 2. Global Adult Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Influenza Product Picture
Figure 4. Cervical Cancer Product Picture
Figure 5. Zoster Shingles Product Picture
Figure 6. Pneumococcal Product Picture
Figure 7. Meningococcal Product Picture
Figure 8. MMRV Product Picture
Figure 9. Hepatitis Product Picture
Figure 10. DTP Product Picture
Figure 11. Travel and Miscellaneous Product Picture
Figure 12. Global Adult Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 13. Hospitals
Figure 14. Medical Care Centers
Figure 15. Other
Figure 16. Global Adult Vaccine Market Size 2015-2026 (US$ Million)
Figure 17. Global Adult Vaccine Sales Capacity (K MT) (2015-2026)
Figure 18. Global Adult Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Adult Vaccine Sales Share by Manufacturers in 2020
Figure 20. Global Adult Vaccine Revenue Share by Manufacturers in 2019
Figure 21. The Global 5 and 10 Largest Players: Market Share by Adult Vaccine Revenue in 2019
Figure 22. Adult Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Adult Vaccine Sales Market Share by Region (2015-2020)
Figure 24. Global Adult Vaccine Sales Market Share by Region in 2019
Figure 25. Global Adult Vaccine Revenue Market Share by Region (2015-2020)
Figure 26. Global Adult Vaccine Revenue Market Share by Region in 2019
Figure 27. North America Adult Vaccine Sales Market Share by Country in 2019
Figure 28. North America Adult Vaccine Revenue Market Share by Country in 2019
Figure 29. U.S. Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 30. U.S. Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Canada Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 32. Canada Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Europe Adult Vaccine Sales Market Share by Country in 2019
Figure 34. Europe Adult Vaccine Revenue Market Share by Country in 2019
Figure 35. Germany Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 36. Germany Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. France Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 38. France Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. U.K. Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 40. U.K. Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Italy Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 42. Italy Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Russia Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 44. Russia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Asia Pacific Adult Vaccine Sales Market Share by Region in 2019
Figure 46. Asia Pacific Adult Vaccine Revenue Market Share by Region in 2019
Figure 47. China Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 48. China Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Japan Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 50. Japan Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. South Korea Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 52. South Korea Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. India Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 54. India Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Australia Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 56. Australia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Taiwan Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 58. Taiwan Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Indonesia Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 60. Indonesia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Thailand Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 62. Thailand Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Malaysia Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 64. Malaysia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Philippines Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 66. Philippines Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Vietnam Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 68. Vietnam Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Latin America Adult Vaccine Sales Market Share by Country in 2019
Figure 70. Latin America Adult Vaccine Revenue Market Share by Country in 2019
Figure 71. Mexico Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 72. Mexico Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Brazil Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 74. Brazil Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Argentina Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 76. Argentina Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Middle East and Africa Adult Vaccine Sales Market Share by Country in 2019
Figure 78. Middle East and Africa Adult Vaccine Revenue Market Share by Country in 2019
Figure 79. Turkey Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Saudi Arabia Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 82. Saudi Arabia Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. U.A.E Adult Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 84. U.A.E Adult Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Sales Market Share of Adult Vaccine by Type (2015-2020)
Figure 86. Sales Market Share of Adult Vaccine by Type in 2019
Figure 87. Revenue Share of Adult Vaccine by Type (2015-2020)
Figure 88. Revenue Market Share of Adult Vaccine by Type in 2019
Figure 89. Global Adult Vaccine Sales Growth by Type (2015-2020) (K MT)
Figure 90. Global Adult Vaccine Sales Market Share by Application (2015-2020)
Figure 91. Global Adult Vaccine Sales Market Share by Application in 2019
Figure 92. Global Revenue Share of Adult Vaccine by Application (2015-2020)
Figure 93. Global Revenue Share of Adult Vaccine by Application in 2020
Figure 94. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. BioCSL (Seqirus) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Protein Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Price Trend of Key Raw Materials
Figure 102. Manufacturing Cost Structure of Adult Vaccine
Figure 103. Manufacturing Process Analysis of Adult Vaccine
Figure 104. Adult Vaccine Industrial Chain Analysis
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. North America Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 109. North America Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Adult Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Adult Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Bottom-up and Top-down Approaches for This Report
Figure 119. Data Triangulation
Figure 120. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs